For more than a century, we’ve studied tissue biology on a slide: a thin section, a stain, a single plane under a microscope. That approach built the foundation of modern pathology and cell biology, but it always carried an inherent limitation. Biology itself was never flat. Cells organize into tissues, tissues fold into organs, and the signals that drive health and disease travel across all three dimensions. Spatial biology and complex in vitro tissue models (CIVM) are letting researchers see tissue architecture and study tissue function the way it actually exists—in 3D.
Put simply, spatial biology combines molecular tools with advanced imaging to map where genes and proteins show up within intact tissue, not just that they’re there. It merges the specificity of classic techniques like immunohistochemistry with the throughput of modern sequencing and imaging platforms. Instead of studying one ultra-thin section, researchers are beginning to measure gene and protein expression in thicker tissues that provide greater spatial context.
Why Tissue Deserves a Third Dimension
Consider the scale problem for a moment. A standard tissue section used in spatial transcriptomics work is remarkably thin, often just 10 microns. A mouse brain, by comparison, is roughly 10 millimeters deep.1 That means a single 2D section captures a sliver of the whole structure, and the rest of the tissue’s architecture never gets examined at all. Recent computational modeling of 3D tissue structure backs up why that matters: when researchers compared 2D sections against full 3D reconstructions, the 2D data frequently produced misleading results, including relationships between cells that simply didn’t hold up once the full tissue volume was considered.2
You can see the practical consequences in familiar research contexts. A 2D section of a tumor can miss how cancer cells invade surrounding tissue, since invasion is inherently a three-dimensional process. A brain section can lose the layered circuitry that gives neurons their function. And a 2D section through a tumor microenvironment may only catch a fraction of the immune cells present, along with how close they sit to one another, both of which can shape how a tumor responds to treatment.3
The same limitation shows up well outside of tissue sections, too. In vitro 2D cell culture has been the workhorse of drug development and toxicology testing for decades, and it’s notorious for failing to predict how a compound will actually behave in a living organism. Cells grown flat, without the extracellular matrix and supporting cell types found in native tissue, just don’t behave the way they do in the body. It’s one of the reasons human-relevant in vitro models, like the new approach methodologies (NAMs) from LifeNet Health® LifeSciences, have become such an important complement to tissue-based spatial work.
How Spatial Multi-omics Captures Structure and Function Together
Spatial transcriptomics and spatial proteomics let researchers map gene and protein expression while holding onto exactly where in the tissue that activity is happening. These fields provide more than a list of which molecules are present, they pinpoint where they sit relative to each other inside cells and within the surrounding tissue.
Layer multiple ‘omic modalities—genomics, transcriptomics, proteomics, and metabolomics—onto a 3D tissue volume, and you get a level of depth 2D methods simply cannot reach. A cell’s identity isn’t defined by its location alone. It’s the combination of which genes are switched on, which proteins it produces, and which signals it’s picking up from its neighbors. Multi-omic analysis in three dimensions starts to capture that fuller picture, and increasingly, AI-assisted pipelines are helping researchers speed up data analysis and reveal connections that would be tough to spot through manual review alone.
The Platforms Making This Possible
Several technologies are fostering this transition to a deeper view of biology in context.
On the imaging-based sequencing side, Stellaromics built its Pyxa platform to bring subcellular-resolution spatial biology to thick, intact tissue instead of thin sections.4 Singular Genomics’ G4X spatial sequencer takes a related approach for FFPE samples, combining targeted transcriptomics, protein detection, and fluorescent H&E on the same tissue section at high throughput.5
On the multiplex immunofluorescence front, platforms like Revolune are focused on making multiplex spatial imaging more accessible to labs currently running IHC, without locking researchers into one closed ecosystem.6
And for teams who want to complement tissue-based spatial data with functional, human-relevant models, LifeNet Health LifeSciences’ NAMs portfolio offers another path to physiologically relevant data, without traditional animal testing.7
Why This Matters for Your Work
Capturing a 3D view of biology is becoming increasingly important to anyone making research or development decisions:
- Diagnostic and prognostic biomarker discovery, including complex multi-marker signatures that a single 2D readout might miss
- Better-informed drug targets, built on a fuller understanding of tumor microenvironments across patient populations
- More precise patient stratification for clinical trials
- Clearer insight into mechanisms of drug resistance
- More accurate disease models, including organoid and complex in vitro models that mimic native tissue architecture
- Earlier detection of pathological changes, since tissue disorganization often precedes visible disease progression
A Shift in How We Study Life
The move to 3D is more than a technical upgrade. It’s a shift from studying biology as a catalog of individual parts toward studying it as an integrated, dynamic system, which is a lot closer to how life actually works.
Telling That Story Well
Explaining spatial biology clearly, without oversimplifying the science or losing a non-specialist reader, is its own kind of expertise. It’s the same expertise we brought to helping Stellaromics launch Pyxa at AGBT, turning a genuinely new kind of instrument into a brand, a booth presence, and a launch story that connected with the scientists in the room.
Whether you need technical content that clearly explains how your product accelerates discovery, or design work that makes a new platform look as compelling as the science behind it, our team has spent years keeping pace with biotech innovation. Take a look at our content and collateral services and design services to see how we approach that work, and reach out anytime. We’d love to talk about your next project.
References
- Technology Networks. “3D and Volumetric Spatial Biology.” technologynetworks.com/tn/articles/3d-and-volumetric-spatial-biology-415603
- bioRxiv. “2D spatial tissue analysis often misrepresents true biological patterns of 3D tissues.” biorxiv.org/content/10.64898/2026.01.21.700966
- Stellaromics. “Why 3D.” stellaromics.com/3d
- Technology Networks. “Bringing Tissue Biology Into 3D: Redefining What’s Possible in Spatial Multiomics.” technologynetworks.com/proteomics/blog/bringing-tissue-biology-into-3d-redefining-whats-possible-in-spatial-multiomics-409584
- Singular Genomics. “G4X In Situ Multiomics.” singulargenomics.com/g4x
- Revolune. revolune.de
- LifeNet Health LifeSciences. “New Approach Methodologies (NAMs).” lnhlifesciences.org/services/nams
